SCHEMBL6830706

SCHEMBL6830706

COC(=O)c1cc(Br)ccc1NC(=O)c1noc2ccc(S(=O)(=O)Cl)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
GAA P10253 1/20 0.43
HIF1A Q16665 5/20 0.41
ABCG2 Q9UNQ0 2/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 5/20 0.38
KMT2A Q03164 4/20 0.38
HSD17B10 Q99714 3/20 0.38
MEN1 O00255 3/20 0.38
TP53 P04637 2/20 0.38
MAPT P10636 2/20 0.38
RECQL P46063 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
USP2 O75604 1/20 0.38
ALOX15 P16050 1/20 0.38
NR4A1 P22736 1/20 0.38
APEX1 P27695 1/20 0.38
PTPN7 P35236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349502 0.81 ALDH1A1 (0.51) ALDH1A1GAAABCG2SMN1; SMN2LMNA
SCHEMBL6833908 0.80 CA1 (0.45) TDP1KDM4E
SCHEMBL6833153 0.79 METAP2 (0.46) HIF1APOLBKMT2AMEN1MAPT
SCHEMBL6822001 0.78 MEN1 (0.43) ALDH1A1GAASMN1; SMN2LMNAPOLB
SCHEMBL6830643 0.78 ALB (0.36) ALDH1A1GAAHIF1ASMN1; SMN2LMNA
SCHEMBL6833947 0.76 AKR1C2 (0.51) ALDH1A1HIF1APOLBKMT2AMEN1
SCHEMBL6833164 0.76 RXFP1 (0.54) ALDH1A1GAASMN1; SMN2LMNAPOLB
SCHEMBL6830645 0.76 ALB (0.48) HIF1A
SCHEMBL22518530 0.76 TSHR (0.51) ALDH1A1HIF1ASMN1; SMN2KMT2AHSD17B10
SCHEMBL30442762 0.76 TSHR (0.51) ALDH1A1HIF1ASMN1; SMN2KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALDH1A1 170/4885GAA 143/4885HIF1A 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.